Floatz logo

Dabigatran

Frailty

Brigham and Women's HospitalDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Frailty cohort.

Asset / SponsorPhaseRating
Metformin
VA Office of Research and Development
Phase 3BB
Mitoquinone mesilate
UConn Health
Phase 2CCC
Tesamorelin
Massachusetts General Hospital
Phase 2CCC
NEPENTHE
University of Oviedo
N/AD
Edoxaban
Brigham and Women's Hospital
D

View all 10 →

Same molecule, other indications

Dabigatran is also rated in:

atrial fibrillationDormant
BBB
Indicative ·
79 / 100
View asset →
atrial flutterDormant
BBB
Indicative ·
78 / 100
View asset →
BleedingDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →